Cherry Hill Mortgage Investment (NYSE:CHMI – Get Free Report) and Dominari (NASDAQ:DOMH – Get Free Report) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.
Profitability
This table compares Cherry Hill Mortgage Investment and Dominari’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cherry Hill Mortgage Investment | 26.43% | 21.74% | 1.85% |
| Dominari | -51.61% | -235.37% | -163.66% |
Analyst Ratings
This is a breakdown of current ratings and price targets for Cherry Hill Mortgage Investment and Dominari, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cherry Hill Mortgage Investment | 1 | 2 | 1 | 0 | 2.00 |
| Dominari | 1 | 0 | 0 | 0 | 1.00 |
Cherry Hill Mortgage Investment presently has a consensus target price of $3.00, indicating a potential upside of 20.24%. Given Cherry Hill Mortgage Investment’s stronger consensus rating and higher possible upside, research analysts plainly believe Cherry Hill Mortgage Investment is more favorable than Dominari.
Risk and Volatility
Cherry Hill Mortgage Investment has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, Dominari has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500.
Institutional & Insider Ownership
18.5% of Cherry Hill Mortgage Investment shares are held by institutional investors. Comparatively, 42.5% of Dominari shares are held by institutional investors. 1.6% of Cherry Hill Mortgage Investment shares are held by company insiders. Comparatively, 55.3% of Dominari shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Cherry Hill Mortgage Investment and Dominari”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cherry Hill Mortgage Investment | $61.10 million | 1.51 | $6.83 million | $0.18 | 13.86 |
| Dominari | $123.10 million | 0.37 | -$22.43 million | ($5.39) | -0.35 |
Cherry Hill Mortgage Investment has higher earnings, but lower revenue than Dominari. Dominari is trading at a lower price-to-earnings ratio than Cherry Hill Mortgage Investment, indicating that it is currently the more affordable of the two stocks.
Summary
Cherry Hill Mortgage Investment beats Dominari on 11 of the 14 factors compared between the two stocks.
About Cherry Hill Mortgage Investment
Cherry Hill Mortgage Investment Corporation, a residential real estate finance company, acquires, invests in, and manages residential mortgage assets in the United States. It operates through Investments in RMBS (residential mortgage-backed securities) and Investments in Servicing Related Assets segments. Cherry Hill Mortgage Investment Corporation qualifies as a real estate investment trust for federal income tax purposes. The company generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Cherry Hill Mortgage Investment Corporation was incorporated in 2012 and is based in Farmingdale, New Jersey.
About Dominari
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
Receive News & Ratings for Cherry Hill Mortgage Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cherry Hill Mortgage Investment and related companies with MarketBeat.com's FREE daily email newsletter.
